small molecule

VIDEX

DIDANOSINE

Loss of exclusivityloss of exclusivity
CompanyBRISTOL MYERS SQUIBB CO PHARMACEUTICAL RESEARCH INSTITUTE

Drug detail

Brand nameVIDEX
Active ingredientDIDANOSINE
Strength100MG/PACKET
Dosage formFOR SOLUTION
RouteORAL
ModalitySmall molecule
FDA approvalOctober 1991
Marketing statusDISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

VIDEX patent cliff — loss of exclusivity — | CliffBio